Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

54 results about "Atp production" patented technology

ATP is produced at the levels of cellular respiration. It is produced and consumed in anaerobic as well as aerobic respiration. The production of ATP consists of three major pathways namely glycolysis, Krebs cycle or citric acid cycle and electron transport phosphorylation or beta oxidation.

Method for preparing adenosine triphosphate with immobilized enzyme method

The invention discloses a method for preparing adenosine triphosphate (ATP) with an immobilized enzyme method. The method comprises the following steps: (1) fixing an ATP production enzyme on an immobilized carrier to prepare an immobilized ATP production enzyme; (2) catalyzing by using the immobilized ATP production enzyme to prepare an adenosine triphosphate reaction solution; (3) separating the product adenosine triphosphate. According to the method disclosed by the invention, three types of novel ATP production enzymes including Ppk, Adk and Pap are adopted, and the ATP can be synthesized through only two steps of enzymatic reaction; a reaction process is simpler, a reaction is more easily controlled and the product quality is more stable; the ATP is prepared by adopting an immobilized enzyme catalysis method, and an immobilized enzyme can he continuously and repeatedly used for a plurality of times, so that the production cost is greatly reduced. Meanwhile, impurities including a lot of proteins, pigments and the like, which are introduced by utilizing yeasts, are avoided, and the product is more easily purified; an intermittent stirring reaction and enzyme reaction column continuous reaction system which is applicable to large-scale production of the ATP is established.
Owner:BEIJING TIANKAI YIDA BIOLOGICAL SCI & TECH

Fibroblast Activator, Collagen Production Promoter, Collagen Contraction Promoter, Hyaluronic Acid Production Promoter, ATP Production Promoter, Melanin Formation Inhibitor, and Agent for External Application to the Skin

The present invention is a fibroblast activator, collagen production promoter, collagen contraction promoter, hyaluronic acid production promoter, ATP production promoter or melanin formation suppressor, which contains, as an active ingredient, at least one kind of compound selected from the group consisting of conagenin, a conagenin derivative, and a pharmaceutically acceptable salt thereof, as well as a composition (skin external preparation, cosmetic, pharmaceutical product or food, which is a composition for the improvement of wrinkles or a whitening composition) containing such activator, promoter or melanin formation suppressor.According to the present invention, a safe skin external preparation, cosmetic (cosmetic composition), pharmaceutical product or food, which shows a high wrinkle improving effect, can be provided, and a safe skin external preparation, cosmetic (cosmetic composition), pharmaceutical product or food, which shows a high whitening effect can be provided.
Owner:KANEKA CORP

Method of improving skin health and compositions therefor

Cosmetic methods of increasing ARE activated gene transcription in a skin cell by contacting skin cells in a target portion of skin with an effective amount of niacinamide and nicotinamide riboside in combination to increase ARE activated gene transcription or synergistically increase ARE activated gene transcription of at least some of the skin cells contacted with the niacinamide and nicotinamide riboside. The cosmetic methods also enable synergistic reduction of ROS-induced adenosine triphosphate (ATP) depletion in a skin cell and restoration of glycolytic ATP production rate in a skin cell that has been reduced as a result of ROS-induced oxidative stress.
Owner:THE PROCTER & GAMBLE COMPANY

Therapeutics for cancer using 3-bromopyruvate and other selective inhibitors of ATP production

The present invention relates to methods of treating a cancerous tumor using selective inhibitors of ATP production. The present invention also relates to pharmaceutical preparations comprising such inhibitors and methods for administering them intraarterially directly to a tumor, as well as methods for identifying compositions that selectively inhibitor ATP production for use in the invention.
Owner:THE JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE

Phenothiazine analogues as mitochondrial therapeutic agents

ActiveUS20180065941A1Decreased mitochondrial functionPrevent ROS-induced damageNervous disorderOrganic chemistryAtp productionPhenothiazine derivative
The present disclosure provides phenothiazine derivative compounds and salts thereof, compositions comprising these compounds, and methods of using these compounds in a variety of applications, such as treatment or suppression of diseases associated with decreased mitochondrial function resulting in diminished ATP production and / or oxidative stress and / or lipid peroxidation.
Owner:ARIZONA STATE UNIVERSITY

Novel aden osyl methionine in vitro enzymatic transformation method

ActiveCN1850980ATo achieve the effect of mutual promotion of reactionsReduce manufacturing costFermentationEnzymatic synthesisS-Adenosyl-l-methionine
The invention provides the new method of composing the SAM by means of the enzyme, (1) using the ATP to producing the bacterium individual plant which can fordizethe ATP; (2) transforming the SAM composing enzyme to produce SAM; the said two actions are connected. The method improves the efficiency of the ATP producing bacterium individual plant producing the ATP greatly and depressing the cost of the ectoenzym out of the cell producing the SAM. So it is the same with the mass production of the SAM.
Owner:上海国佳生化工程技术研究中心有限公司 +1

Cell nutrition enhancing health product preparation and preparation method thereof

The present invention discloses a cell nutrition enhancing health product preparation and a preparation method thereof, and relates to the technical field of health care products, the cell nutrition enhancing health product preparation is made from the following materials: wall-broken ganoderma lucidum spore powder, selenium-rich yeast, dendrobium officinale freeze-dried powder, ganoderma lucidum extract, astragalus extract, wolfberry extract, rhizoma polygonati powder, Ganoderma sinensis powder, Antrodia powder, American ginseng powder, lentinan, pine pollen, spirulina powder and royal jelly powder, the cell nutrition enhancing health product preparation can activate the electronic delivery system on mitochondrial inner membrane, increase cell mitochondrial ATP production, fundamentally supplement cellular energy, eliminate cell fatigue, and enhance cell regeneration ability, and is free of side effects, by insisting on taking, the cell nutrition enhancing health product preparation helps to enhance physique and improve health state, and is suitable for the sub-health crowd to take.
Owner:安徽千方生物科技有限公司

Systems and methods for determining production availability

A system for managing production availability. A storage device stores a production entry corresponding to a client for production using a particular technology. The production entry comprises a demand profile and a production availability profile. The demand profile specifies the amount of capacity allocated support demand (CASD) for the client during a preset period, comprising a non-booked CASD and a booked CASD. The production availability profile specifies available-to-promise (ATP) production corresponding to the non-booked CASD, comprising production values specifying quantities of ATP production allocated to the client during different divisions of the preset period. The processor, connected to the storage device, updates an existing production availability profile according to an existing demand profile, wherein the production values of the updated production availability profile are determined according to the existing CASD profile and ratios of the production values of the existing production availability profile.
Owner:TAIWAN SEMICON MFG CO LTD

A biological fertilizer based on yeasts

The present invention provides biofertilizer compositions comprising yeast cells with enhanced fixation of atmospheric nitrogen, decomposition of inorganic phosphorus and its compounds, decomposition of inorganic potassium and its compounds, decomposition of complex carbon compounds, overproduction of growth factors and excess Ability to produce ATP. The biological fertilizer composition of the invention can replace inorganic fertilizers to provide nitrogen, phosphorus and potassium to crops. The invention also includes a production method and an application method of the biological fertilizer composition.
Owner:ULTRA BIOTECH

Substituted phenothiazines as mitochondrial agents

ActiveUS10472340B2Prevent ROS-induced damageMaintain mitochondrial membrane potentialOrganic active ingredientsNervous disorderAtp productionPhenothiazine derivative
The present disclosure provides phenothiazine derivative compounds and salts thereof, compositions comprising these compounds, and methods of using these compounds in a variety of applications, such as treatment or suppression of diseases associated with decreased mitochondrial function resulting in diminished ATP production and / or oxidative stress and / or lipid peroxidation.
Owner:ARIZONA STATE UNIVERSITY

Medical Bioelectric Plasma Beam

Disclosed is a device having an oscillator and high voltage transformer connected to a glass-like tube filled with an inert gas or a mixture of inert gasses. The tube is located at the end of a wand having a handle. The output of the transformer is an RF high voltage signal. The output of the transformer is fed to the tube through a high voltage wire, where the signal excites the gas to produce a plasma-like beam. The tube is then applied to a patient's skin to aid in healing and the relief of additional ailments. The field generated by the tube interacts with the cells in the patient to increase transmembrane potential, stimulate ATP production, and inject negative ions and ozone into the surface of the user's skin to combat infection and disease.
Owner:LUMIGENCE LLC

Synergistic compositions useful as cytostatic, bacteriostatic and/or virostatic agents

The inventor has surprisingly found that a combination of water-soluble organic compounds provides a synergistic effect that efficiently blocks ATP production by the aerobic pathway. More particularly, such a synergistic composition lowers the level of energy or production of ATP to a point where cells and specifically cancer cells, stop dividing. In this connection, the present invention provides a synergistic composition which is particularly useful as potent cytostatic and / or antibiotic agents and their use in methods for treating cancers and / or bacterial infections.
Owner:GRIGUER CORINNE E

Method for preparing adenosine triphosphate by immobilized enzyme method

The invention discloses a method for preparing adenosine triphosphate (ATP) with an immobilized enzyme method. The method comprises the following steps: (1) fixing an ATP production enzyme on an immobilized carrier to prepare an immobilized ATP production enzyme; (2) catalyzing by using the immobilized ATP production enzyme to prepare an adenosine triphosphate reaction solution; (3) separating the product adenosine triphosphate. According to the method disclosed by the invention, three types of novel ATP production enzymes including Ppk, Adk and Pap are adopted, and the ATP can be synthesized through only two steps of enzymatic reaction; a reaction process is simpler, a reaction is more easily controlled and the product quality is more stable; the ATP is prepared by adopting an immobilized enzyme catalysis method, and an immobilized enzyme can he continuously and repeatedly used for a plurality of times, so that the production cost is greatly reduced. Meanwhile, impurities including a lot of proteins, pigments and the like, which are introduced by utilizing yeasts, are avoided, and the product is more easily purified; an intermittent stirring reaction and enzyme reaction column continuous reaction system which is applicable to large-scale production of the ATP is established.
Owner:BEIJING TIANKAI YIDA BIOLOGICAL SCI & TECH

Tocopherol and tocopheryl quinone derivatives as correctors of Lysosomal Storage Disorders

The subject invention relates to improved tocopheryl quinone derivatives and tocopherol derivatives having improved pharmacokinetics in vivo that can, in some embodiments, be useful in the treatment of Lysosomal Storage Disorders, restoration of normal mitochondrial ATP production, modulation of intracellular calcium ion concentration and other treatments or therapies. The tocopheryl quinone derivatives and tocopherol derivatives have side chains that have terminally halogenated carbon atoms.
Owner:UNITED STATES OF AMERICA

Methods of treatment using 3-bromopyruvate and other selective inhibitors of atp production

InactiveUS20150359764A1Preventing and treating bacterial infectionPromote wound healingAntibacterial agentsBiocideMedicineAtp production
The present invention provides methods for preventing or treating infections, especially bacterial infections, by administering selective inhibitors of ATP production to inhibit glycolytic enzymes, such as glyceraldehyde 3-phosphate dehydrogenase (GAPDH). As such, the present invention further provides methods for preventing or treating inflammation and sepsis associated with infections, as well as increased wound healing and decreased wound scarring.
Owner:PRESCI LABS

Nutritional product composition for energy

A nutritional product composition for energy, to increase intracellular ATP production, assist the body in making more energy without the use of caffeine and stimulants and combat fatigue on a cellular level. The nutritional product composition for energy includes a synergistic blend of nutrients and a silica gel that increases the rate of metabolism of cells to increase the rate of absorption of the nutrients and increase energy production. The synergistic blend of nutrients includes vitamin C, thiamin, riboflavin, niacin, vitamin B6, folate, vitamin B12, d-biotin, pantothenic acid, calcium, selenium, copper and chromium. The silica gel increases an absorption rate of the synergistic blend.
Owner:LIFEWAVE

Methods of Treatment Using 3-Bromopyruvate and Other Selective Inhibitors of ATP Production

InactiveUS20130046019A1Preventing and treating sepsisPromote wound healingAntibacterial agentsBiocideMedicineAtp production
The present invention provides methods for preventing or treating infections, especially bacterial infections, by administering selective inhibitors of ATP production to inhibit glycolytic enzymes, such as glyceraldehyde 3-phosphate dehydrogenase (GAPDH). As such, the present invention further provides methods for preventing or treating inflammation and sepsis associated with infections, as well as increased wound healing and decreased wound scarring.
Owner:PRESCI LABS

A method for enzymatically preparing adenosine triphosphate

The invention discloses a method for preparing triphosadenine by an enzymic method. The method comprises the following steps of (1) preparing ATP production enzymes: obtaining the ATP production enzymes in gene engineering transformation, fermentation, purification or direct extraction modes; (2) preparing ATP in reaction liquid; adding adenosine, the ATP production enzymes and polyphosphoric acid or salts of the polyphosphoric acid for ATP preparation; (3) separating products and ATP production enzymes; directly separating immobilized ATP production enzymes in a reaction tank, and separating free ATP production enzymes through an ultrafiltration membrane in a filtering device; (4) preparing a finished product: preparing the reaction liquid subjected to the enzyme separation into finished product ATP through the steps of ion-exchange column chromatography, concentration, crystallization; drying and the like. The method has the advantages that the novel ATP production enzymes are used; the production process is simple; the control is easy; the adenosine is used as a substrate; the cost is reduced; an APT production enzyme recovery system is built; the method is applicable to industrial production; the content of impurities such as impurity protein and pigment in the enzymic method preparation reaction liquid is low; the subsequent purification is easy.
Owner:BEIJING TIANKAI YIDA BIOLOGICAL SCI & TECH

Prodrugs of Succinic Acid for Increasing ATP Production

The present invention provides novel cell-permeable succinates and cell permeable precursors of succinate aimed at increasing ATP-production in mitochondria. The main part of ATP produced and utilized in the eukaryotic cell originates from mitochondrial oxidative phosphorylation, a process to which high-energy electrons are provided by the Kreb's cycle. Not all Kreb's cycle intermediates are readily permeable to the cellular membrane, one of them being succinate. The provision of the novel cell permeable succinates is envisaged to allow passage over the cellular membrane and thus the cell permeable succinates can be used to enhance mitochondrial ATP-output.
Owner:NEUROVIVE PHARMA AB
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products